UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	December 15, 2020 9:00 A.M.

Form:	S-4
CIK: 0001743881 Company Name: BridgeBio Pharma, Inc. File Number: 333-249944